- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03426358
Liver Stiffness Measurement Predicts VOD/SOS Development (ELASTOVOD ITALIAN MULTICENTRIC STUDY) (ELASTOVOD)
Usefulness of Liver Stiffness Measurement in Predicting Hepatic Veno-Occlusive Disease Development in Patients Who Undergo HSCT: a Multicentric Prospective Study
ELASTOVOD is a prospective multicenter study, involving several centers of Onco-haematology in Italy. Investigators perform hepatic elastographic measurements (with Transient Elastography, ARFI or 2D-SWE) on patients undergoing HSCT, at baseline before transplantation (T0) and at T1/T2/T3 after HSCT (+9/10, +15/17, +22/24).
SOS/VOD diagnosis was performed according to clinical criteria.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Sinusoidal Obstruction Syndrome (SOS), also known as hepatic Veno-Occlusive Disease (VOD), is a life-threatening complication in patients undergoing Hematopoietic Stem Cells Transplantation (HSCT) for onco-haematological disease.
In the severe form, mortality rate can be high as 80%. Patients developing SOS/VOD present a higher survival rate when earlier SOS/VOD- specific therapy has initiated. In order to get better outcomes, it is necessary to improve early diagnosis of SOS/VOD, finding new non--invasive diagnostic instruments.
The aim of this prospective multicenter study is to assess in a large, mixed (adult and paediatric) population undergoing HSCT, the diagnostic role for SOS/VOS of Liver Stiffness Measurement (LSM), assessed by different elastographic methods.
In our study, Liver Stiffness Measurement (LSM) can be measured by Transient Elastography (TE) with Fibroscan, Acoustic Radiation Force Impulse (ARFI) or 2D-Share Wave Elastography (2D-SWE). Once chosen an elastometric method at baseline, the same must be used for all subsequent evaluations of the patient.
In patients undergoing HSCT, within one month, a complete baseline evaluation is provided. Baseline evaluation (T0) includes: signature of informed consent, haematological and hepatological anamnesis, in order to assess comorbidities and risk factors for hepato-biliary complications; complete laboratory tests; abdominal Color-Doppler Ultrasound and hepatic Elastography (with Transient Elastography, ARFI or 2D-SWE).
After conditioning and HSCT, each patient is evaluated at T1 (+9/10), T2 (+15/17), T3 (+22/24) with: bedside Elastography, laboratory tests, clinical examination based on clinical criteria for SOS/VOD diagnosis (e.g. Baltimora criteria, modified Seattle criteria, new EBMT criteria).
RUCAM-CIOMS Scale can be assess, in order to establish DILI (Drug Induced Liver Injury) diagnosis, as well.
In case of SOS/VOD suspicion, patient goes through an intense monitoring period: laboratory tests, clinical evaluation for SOS/VOD diagnosis, Color-Doppler US and Elastography are repeatedly performed in next days. This monitoring period stops if diagnosis of SOS/VOD or other diagnosis is reached.
Each center will prospectively collect data according to an electronic e-CFR on REDCap (Research Electronic Data Capture) system, a web application designed to support data capture for research studies in a secure manner.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Alessandria, Italy
- Azienda Ospedaliera-Nazionale SS. Antonio e Biagio e Cesare Arrigo
-
Ancona, Italy
- Azienda Ospedaliero-Universitaria Ospedali Riuniti di Ancona
-
Bari, Italy
- Azienda Ospedaliero-Universitaria Consorziale - Policlinico di Bari
-
Bergamo, Italy
- ASST Papa Giovanni XXIII Ospedali riuniti di Bergamo
-
Bolzano, Italy
- Azienda Sanitaria dell'Alto Adige
-
Brescia, Italy
- Spedali Civili di Brescia, UO Ematologia
-
Catania, Italy
- Policlinico Vittorio Emanuele - Presidio Ferrarotto
-
Firenze, Italy
- Azienda Ospedaliera-Universitaria Careggi
-
Firenze, Italy
- Azienda Ospedaliera-Universitaria Meyer
-
Genova, Italy
- Ospedale Policlinico San Martino
-
Lecce, Italy
- Ospedale Vito Fazzi
-
Mestre, Italy
- Ospedale dell'Angelo
-
Milano, Italy
- Ospedale San Raffaele
-
Milano, Italy
- ASST Grande Ospedale Metropolitano Niguarda
-
Milano, Italy
- Ospedale Maggiore Policlinico di Milano
-
Modena, Italy
- Azienda Ospedaliera-Universitaria di Modena
-
Napoli, Italy
- Policlinico Federico II
-
Napoli, Italy
- Ospedale Pediatrico Pausilipon
-
Padova, Italy
- Azienda Ospedaliero-Universitaria di Padova
-
Palermo, Italy
- Azienda Ospedaliera Ospedali riuniti Villa Sofia- Cervello
-
Parma, Italy
- Azienda Ospedaliero-Universitaria Ospedale Maggiore di Parma
-
Pescara, Italy
- Azienda Sanitaria Locale di Pescara
-
Pisa, Italy
- Azienda Ospedaliero-universitaria Pisana, UO Ematologia
-
Pisa, Italy
- Azienda Ospedaliero-Universitaria Pisana, UO Oncoematologia Pediatrica
-
Reggio Emilia, Italy
- Arcispedale S. Maria Nuova di Reggio Emilia
-
Roma, Italy
- Ospedale Pediatrico Bambino Gesù
-
Roma, Italy
- Policlinico Universitario A. Gemelli
-
Roma, Italy
- Policlinico Tor Vergata
-
Torino, Italy
- Azienda Ospedaliero-Universitaria Città della Salute e della Scienza
-
Udine, Italy
- Azienda Ospedaliero-Universitaria Integrata di Udine
-
Verona, Italy
- Azienda Ospedaliero-Universitaria Integrata di Verona
-
Vicenza, Italy
- Azienda Ospedaliera di Vicenza
-
-
BO
-
Bologna, BO, Italy
- Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi.
-
-
Foggia
-
San Giovanni Rotondo, Foggia, Italy
- Casa Sollievo della Sofferenza
-
-
Lecce
-
Tricase, Lecce, Italy
- Azienda Ospedaliera "Card. G. Panico"
-
-
Milano
-
Rozzano, Milano, Italy
- Istituto Clinico Humanitas
-
-
RM
-
Roma, RM, Italy
- Policlinico Umberto I - Università La Sapienza
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- male or female patients
- age between 3 and 70
- patients suffering from an onco-hematological disease that have an indication for either allogenic or autologous hematopoietic stem cells transplantation
- obtaining of informed consent
Exclusion Criteria:
- pathological obesity (BMI >40)
- pacemaker of implantable defibrillator
- presence of ascites at baseline
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Patients undergoing HSCT
LSM assessed by Elastographic Techniques
|
Performing Transient Elastography, ARFI or 2D-SWE on patients at baseline (within 1 month before HSCT) and after HSCT on days +9/10, +15/17, +22/24
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Diagnostic Role of Liver Stiffness Measurement in SOS/VOD development
Time Frame: From HSCT to 30 days after HSCT
|
To assess in a large, mixed (adult and paediatric) population undergoing HSCT, the role of Liver Stiffness Measurement (LSM), assessed by different elastographic methods, in SOS/VOD diagnosis.
|
From HSCT to 30 days after HSCT
|
Collaborators and Investigators
Investigators
- Principal Investigator: Antonio Colecchia, M.D., Azienda Ospedaliera-Universitaria Integrata di Verona
- Study Chair: Francesca Bonifazi, Ph.D. M.D., Azienda Ospedaliera-Universitaria Sant'Orsola Malpighi di Bologna
- Study Chair: Andrea Passion, Prof. M.D., Azienda Ospedaliera-Universitaria Sant'Orsola Malpighi di Bologna
Publications and helpful links
General Publications
- Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG, Storer B. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood. 2005 Oct 15;106(8):2912-9. doi: 10.1182/blood-2005-05-2004. Epub 2005 Jun 30.
- Bamber J, Cosgrove D, Dietrich CF, Fromageau J, Bojunga J, Calliada F, Cantisani V, Correas JM, D'Onofrio M, Drakonaki EE, Fink M, Friedrich-Rust M, Gilja OH, Havre RF, Jenssen C, Klauser AS, Ohlinger R, Saftoiu A, Schaefer F, Sporea I, Piscaglia F. EFSUMB guidelines and recommendations on the clinical use of ultrasound elastography. Part 1: Basic principles and technology. Ultraschall Med. 2013 Apr;34(2):169-84. doi: 10.1055/s-0033-1335205. Epub 2013 Apr 4.
- Corbacioglu S, Carreras E, Ansari M, Balduzzi A, Cesaro S, Dalle JH, Dignan F, Gibson B, Guengoer T, Gruhn B, Lankester A, Locatelli F, Pagliuca A, Peters C, Richardson PG, Schulz AS, Sedlacek P, Stein J, Sykora KW, Toporski J, Trigoso E, Vetteranta K, Wachowiak J, Wallhult E, Wynn R, Yaniv I, Yesilipek A, Mohty M, Bader P. Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation. Bone Marrow Transplant. 2018 Feb;53(2):138-145. doi: 10.1038/bmt.2017.161. Epub 2017 Jul 31.
- Fontanilla T, Hernando CG, Claros JC, Bautista G, Minaya J, Del Carmen Vega M, Piazza A, Mendez S, Rodriguez C, Aranguena RP. Acoustic radiation force impulse elastography and contrast-enhanced sonography of sinusoidal obstructive syndrome (Veno-occlusive Disease): preliminary results. J Ultrasound Med. 2011 Nov;30(11):1593-8. doi: 10.7863/jum.2011.30.11.1593.
- Jones RJ, Lee KS, Beschorner WE, Vogel VG, Grochow LB, Braine HG, Vogelsang GB, Sensenbrenner LL, Santos GW, Saral R. Venoocclusive disease of the liver following bone marrow transplantation. Transplantation. 1987 Dec;44(6):778-83. doi: 10.1097/00007890-198712000-00011.
- Lassau N, Leclere J, Auperin A, Bourhis JH, Hartmann O, Valteau-Couanet D, Benhamou E, Bosq J, Ibrahim A, Girinski T, Pico JL, Roche A. Hepatic veno-occlusive disease after myeloablative treatment and bone marrow transplantation: value of gray-scale and Doppler US in 100 patients. Radiology. 1997 Aug;204(2):545-52. doi: 10.1148/radiology.204.2.9240551.
- McDonald GB, Sharma P, Matthews DE, Shulman HM, Thomas ED. Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology. 1984 Jan-Feb;4(1):116-22. doi: 10.1002/hep.1840040121.
- Richardson PG, Smith AR, Triplett BM, Kernan NA, Grupp SA, Antin JH, Lehmann L, Miloslavsky M, Hume R, Hannah AL, Nejadnik B, Soiffer RJ. Earlier defibrotide initiation post-diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome improves Day +100 survival following haematopoietic stem cell transplantation. Br J Haematol. 2017 Jul;178(1):112-118. doi: 10.1111/bjh.14727. Epub 2017 Apr 26.
- Wadleigh M, Ho V, Momtaz P, Richardson P. Hepatic veno-occlusive disease: pathogenesis, diagnosis and treatment. Curr Opin Hematol. 2003 Nov;10(6):451-62. doi: 10.1097/00062752-200311000-00010.
- McDonald GB. Hepatobiliary complications of hematopoietic cell transplantation, 40 years on. Hepatology. 2010 Apr;51(4):1450-60. doi: 10.1002/hep.23533.
- Carreras E, Diaz-Beya M, Rosinol L, Martinez C, Fernandez-Aviles F, Rovira M. The incidence of veno-occlusive disease following allogeneic hematopoietic stem cell transplantation has diminished and the outcome improved over the last decade. Biol Blood Marrow Transplant. 2011 Nov;17(11):1713-20. doi: 10.1016/j.bbmt.2011.06.006. Epub 2011 Jun 25.
- Mohty M, Malard F, Abecassis M, Aerts E, Alaskar AS, Aljurf M, Arat M, Bader P, Baron F, Bazarbachi A, Blaise D, Ciceri F, Corbacioglu S, Dalle JH, Dignan F, Fukuda T, Huynh A, Masszi T, Michallet M, Nagler A, NiChonghaile M, Okamoto S, Pagliuca A, Peters C, Petersen FB, Richardson PG, Ruutu T, Savani BN, Wallhult E, Yakoub-Agha I, Duarte RF, Carreras E. Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation. Bone Marrow Transplant. 2016 Jul;51(7):906-12. doi: 10.1038/bmt.2016.130. Epub 2016 May 16.
- Dignan FL, Wynn RF, Hadzic N, Karani J, Quaglia A, Pagliuca A, Veys P, Potter MN; Haemato-oncology Task Force of British Committee for Standards in Haematology; British Society for Blood and Marrow Transplantation. BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation. Br J Haematol. 2013 Nov;163(4):444-57. doi: 10.1111/bjh.12558. Epub 2013 Sep 17.
- Berzigotti A, Castera L. Update on ultrasound imaging of liver fibrosis. J Hepatol. 2013 Jul;59(1):180-2. doi: 10.1016/j.jhep.2012.12.028. Epub 2013 Jan 15. No abstract available.
- Lassau N, Auperin A, Leclere J, Bennaceur A, Valteau-Couanet D, Hartmann O. Prognostic value of doppler-ultrasonography in hepatic veno-occlusive disease. Transplantation. 2002 Jul 15;74(1):60-6. doi: 10.1097/00007890-200207150-00011.
- Karlas T, Weber J, Nehring C, Kronenberger R, Tenckhoff H, Mossner J, Niederwieser D, Troltzsch M, Lange T, Keim V. Value of liver elastography and abdominal ultrasound for detection of complications of allogeneic hemopoietic SCT. Bone Marrow Transplant. 2014 Jun;49(6):806-11. doi: 10.1038/bmt.2014.61. Epub 2014 Apr 7.
- Auberger J, Graziadei I, Clausen J, Vogel W, Nachbaur D. Non-invasive transient elastography for the prediction of liver toxicity following hematopoietic SCT. Bone Marrow Transplant. 2013 Jan;48(1):159-60. doi: 10.1038/bmt.2012.113. Epub 2012 Jun 18. No abstract available.
- Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier C, Mal F, Christidis C, Ziol M, Poulet B, Kazemi F, Beaugrand M, Palau R. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 2003 Dec;29(12):1705-13. doi: 10.1016/j.ultrasmedbio.2003.07.001.
- Bureau C, Metivier S, Peron JM, Selves J, Robic MA, Gourraud PA, Rouquet O, Dupuis E, Alric L, Vinel JP. Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease. Aliment Pharmacol Ther. 2008 Jun;27(12):1261-8. doi: 10.1111/j.1365-2036.2008.03701.x. Epub 2008 Apr 4.
- Bota S, Herkner H, Sporea I, Salzl P, Sirli R, Neghina AM, Peck-Radosavljevic M. Meta-analysis: ARFI elastography versus transient elastography for the evaluation of liver fibrosis. Liver Int. 2013 Sep;33(8):1138-47. doi: 10.1111/liv.12240. Epub 2013 Jul 16.
- Millonig G, Reimann FM, Friedrich S, Fonouni H, Mehrabi A, Buchler MW, Seitz HK, Mueller S. Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis. Hepatology. 2008 Nov;48(5):1718-23. doi: 10.1002/hep.22577.
- Lucena MI, Garcia-Cortes M, Cueto R, Lopez-Duran J, Andrade RJ. Assessment of drug-induced liver injury in clinical practice. Fundam Clin Pharmacol. 2008 Apr;22(2):141-58. doi: 10.1111/j.1472-8206.2008.00566.x. Erratum In: Fundam Clin Pharmacol. 2009 Feb;23(1):147.
- del Campo L, Leon NG, Palacios DC, Lagana C, Tagarro D. Abdominal complications following hematopoietic stem cell transplantation. Radiographics. 2014 Mar-Apr;34(2):396-412. doi: 10.1148/rg.342135046.
- Mohty M, Malard F, Abecassis M, Aerts E, Alaskar AS, Aljurf M, Arat M, Bader P, Baron F, Bazarbachi A, Blaise D, Ciceri F, Corbacioglu S, Dalle JH, Duarte RF, Fukuda T, Huynh A, Masszi T, Michallet M, Nagler A, NiChonghaile M, Pagluica T, Peters C, Petersen FB, Richardson PG, Ruutu T, Savani BN, Wallhult E, Yakoub-Agha I, Carreras E. Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives-a position statement from the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant. 2015 Jun;50(6):781-9. doi: 10.1038/bmt.2015.52. Epub 2015 Mar 23.
- Colecchia A, Marasco G, Ravaioli F, Kleinschmidt K, Masetti R, Prete A, Pession A, Festi D. Usefulness of liver stiffness measurement in predicting hepatic veno-occlusive disease development in patients who undergo HSCT. Bone Marrow Transplant. 2017 Mar;52(3):494-497. doi: 10.1038/bmt.2016.320. Epub 2016 Dec 12. No abstract available.
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- ELASTOVOD
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stem Cell Transplant Complications
-
Peking University People's HospitalActive, not recruitingStem Cell Transplant ComplicationsChina
-
Massachusetts General HospitalCompletedStem Cell Transplant ComplicationsUnited States
-
Henry Ford Health SystemRecruitingStem Cell Transplant ComplicationsUnited States
-
University Hospital, EssenUniversity Of Perugia; Institut Paoli-Calmettes; Medical University of Warsaw; Universität... and other collaboratorsNot yet recruitingSurvivorship | Stem Cell Transplant Complications
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaMariarosaria Sessa, MD; Mario Arpinati, MD; Francesco Barbato, MDRecruitingAging | Stem Cell Transplant ComplicationsItaly
-
Children's Hospital of PhiladelphiaRutgers University; NJ Dept of Health Commission on Cancer ResearchCompleted
-
King Faisal Specialist Hospital and Research Centre...CompletedPulmonary Complication | Stem Cell Transplant ComplicationsSaudi Arabia
-
Peking University People's HospitalUnknown
-
Radboud University Medical CenterEnrolling by invitationStem Cell Transplant Complications | Oral ComplicationNetherlands
-
AHS Cancer Control AlbertaNot yet recruiting
Clinical Trials on LSM assessed by Elastographic Techniques
-
KorianRecruitingChronic Obstructive Pulmonary DiseaseFrance
-
Peking University Third HospitalNot yet recruitingAcute Kidney Injury | Intensive Care Unit | UltrasoundChina
-
BioMarin PharmaceuticalTerminatedLate-onset Pompe DiseaseUnited States, United Kingdom
-
University Hospital, Basel, SwitzerlandCompletedInfectious Diseases and ManifestationsSwitzerland
-
Asmaa Nabil ElboraeyNational Research Centre, EgyptActive, not recruitingProblem With DenturesEgypt
-
Pavol Jozef Safarik UniversityUnknown
-
Federal University of São PauloSens4careRecruiting
-
Makerere UniversityLondon School of Hygiene and Tropical Medicine; Karolinska InstitutetCompletedIncomplete AbortionUganda
-
Shandong Province Centers for Disease Control and...Centers for Disease Control and Prevention, China; National Institutes for...Completed
-
University Hospital, CaenUnknown